Expedited regulatory paths transform colorectal cancer treatment, enhancing access but creating challenges in clinical evidence and payer decisions.
Stellantis confirms a data breach tied to Salesforce attacks, exposing customer contact info and sparking phishing warnings.
Learn how the FDA’s new pilot program accelerates generic drug approvals and boosts U.S. pharmaceutical manufacturing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results